Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma

BACKGROUND: Glioma is the most common primary brain tumor, representing approximately 80.8% of malignant tumors. Necroptosis triggers and enhances antitumor immunity and is expected to be a new target for tumor immunotherapy. The effectiveness of necroptosis-related lncRNAs as potential therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Fan, Zhan, Zheng, Yang, Yanbo, Liu, Guangjie, Liu, Song, Gu, Jingyu, Chen, Zhouqing, Wang, Zhong, Chen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440826/
https://www.ncbi.nlm.nih.gov/pubmed/36065303
http://dx.doi.org/10.1155/2022/5681206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440826/
https://www.ncbi.nlm.nih.gov/pubmed/36065303
http://dx.doi.org/10.1155/2022/5681206

Ejemplares similares